RT Book, Section
A1 Hayase, Justin
A1 Shivkumar, Kalyanam
A1 Bradfield, Jason S.
A2 Fuster, Valentin
A2 Narula, Jagat
A2 Vaishnava, Prashant
A2 Leon, Martin B.
A2 Callans, David J.
A2 Rumsfeld, John S.
A2 Poppas, Athena
SR Print(0)
ID 1202447458
T1 Ventricular Arrhythmias and Sudden Cardiac Death
T2 Fuster and Hurst's The Heart, 15e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264257560
LK accesscardiology.mhmedical.com/content.aspx?aid=1202447458
RD 2024/10/10
AB Chapter  SummaryThis  chapter  discusses  the  epidemiology  and  pathophysiology  of  sudden  cardiac  death  (SCD),  which  is  most  often  caused  by  ventricular  arrhythmias,  and  addresses  some  of  the  key  considerations  for  the  evaluation  and  treatment  of  ventricular  arrhythmias.  Major  risk  factors  for  developing  these  arrhythmias  include  cardiac  structural  abnormalities  and  coronary  artery  disease  (CAD)  (see  Fuster  and  Hurst’s  Central  Illustration).  Moreover,  a  number  of  inherited  channelopathies  can  predispose  to  these  arrhythmias  and  should  be  considered  in  the  context  of  a  structurally  normal  heart.  Ventricular  arrhythmias  can  range  from  idiopathic  premature  ventricular  complexes,  to  monomorphic  ventricular  tachycardia  (VT),  to  ventricular  fibrillation  (VF).  Management  of  ventricular  arrhythmias  requires  a  comprehensive  approach  that  may  involve  multiple  therapies,  including  an  implantable  cardioverter  defibrillator  (ICD),  antiarrhythmic  medications,  catheter  ablation,  and/or  autonomic  modulation.  The  decision-making  process  for  management  depends  highly  upon  the  presence  of  underlying  structural  abnormalities.